Crusekitug
Based on 1 Customer Validation
Crusekitug is a humanized monoclonal antibody targeting human interleukin 17A (IL-17A). Crusekitug specifically binds to IL-17A, blocking its signal transduction, thus exerting immunosuppressive and anti-inflammatory activities. Crusekitug is promising for research of autoimmune and inflammatory diseases, such as psoriasis and rheumatoid arthritis.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza: 97.949%
- No. CAS: 2956768-50-4
- Peso molecular:144.985 kDa
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
Isotype
Human IgG1 kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
|
IL-17A |
Gene ID
Accession
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
IgG1-kappa
Aplicación
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized HY-P70527 IL-17A Protein, Human (HEK293, His) can bind Crusekitug. The EC50 for this effect is 43.03 ng/mL.
Chemical Information
-
No. CAS 2956768-50-4
-
Appearance Liquid
-
Peso molecular 144.985 kDa
-
Color Colorless to light yellow
-
SMILES
[Crusekitug]
-
Synonyms
QX-002N
-
Envío
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)